Lavannya M Pandit MD
Critical Care Medicine, Pleural Disease
Assistant Professor, Pulmonology, Baylor College of Medicine
Join to View Full Profile
1 Baylor Plz# JonesHouston, TX 77030
Phone+1 713-798-2400
Dr. Pandit is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Baylor College of MedicineFellowship, Pulmonary Disease and Critical Care Medicine, 2004 - 2008
University of Iowa Health Care Medical CenterResidency, Internal Medicine, 2000 - 2003
University of Texas Southwestern Medical SchoolClass of 2000
Certifications & Licensure
TX State Medical License 2008 - 2027
IA State Medical License 2000 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- Inhibition of BMPER Mitigates Pulmonary Hypertension by Modulating LRP1-YAP Interaction in Smooth Muscle Cells.Hua Mao, Claire M Li, Bing Sun, Christopher S Ward, Alan R Waich-Cohen
Arteriosclerosis, Thrombosis, and Vascular Biology. 2025-11-01 - Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis.Ryan Geffin, Shazia Raheem, Lavannya M Pandit, Andrew S Hunter, Michael W Holliday Jr
Journal of Investigative Medicine High Impact Case Reports. 2023-09-21 - 8 citationsAssociation of Glucose-6-Phosphate Dehydrogenase Deficiency With Outcomes in US Veterans With COVID-19.Sarah H Elsea, Javad Razjouyan, Kyung Min Lee, Julie A Lynch, Sharyl Martini
JAMA Network Open. 2023-03-01
Journal Articles
- Tocilizumab in Patients Hospitalized with Covid-19 PneumoniaGerard J Criner, Lavannya Pandit, The New England Journal of Medicine
Press Mentions
Common Enzyme Deficiency Linked with COVID SeverityMarch 29th, 2023- Why Science Shouldn’t Be ‘Colorblind’June 18th, 2021
- Trial Results Show Potential Benefits of Tocilizumab for COVID-19February 25th, 2021
Grant Support
- A Novel Mechanism of Vascular Remodeling in Interstitial Lung Disease Associated Pulmonary HypertensionMICHAEL E DEBAKEY VA MEDICAL CENTER2026–2029
- The pathophysiology of vascular remodeling in pulmonary hypertensionBAYLOR COLLEGE OF MEDICINE2024–2028
- Anatomic microniches and their contribution to vascular remodeling in pulmonary hypertensionMICHAEL E DEBAKEY VA MEDICAL CENTER2021–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
